DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

To provide a method for the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas).SOLUTION: The invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous adminis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LI CHIUNG, CAROL ELAINE O'HEAR, BRENDAN CHRISTIAN BENDER
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide a method for the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas).SOLUTION: The invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous administration of an anti-CD20/anti-CD3 bispecific antibody (e.g., mosunetuzumab).SELECTED DRAWING: None 【課題】ＣＤ２０陽性細胞増殖性障害（例えば、非ホジキンリンパ腫等のＢ細胞増殖性障害）を有する対象を処置する方法を提供する。【解決手段】抗ＣＤ２０／抗ＣＤ３二重特異性抗体（例えば、モスネツズマブ）の静脈内投与により、Ｂ細胞増殖性障害を有する対象を処置する。【選択図】なし